
Knee Hyaluronic Acid Injections Market Report 2026
Global Outlook – By Product Type (Single Injection, Three Injection, Five Injection), By Indication (Knee Osteoarthritis, Ligament Injury, Post Arthroscopy, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Osteoarthritis, Rheumatoid Arthritis, Other Applications), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Knee Hyaluronic Acid Injections Market Overview
• Knee Hyaluronic Acid Injections market size has reached to $3.17 billion in 2025 • Expected to grow to $4.35 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: Rising Incidence Of Obesity Driving The Growth Of The Market Due To Increasing Osteoarthritis Risk And Demand For Joint Pain Management Solutions • Market Trend: Shift Toward Single-Injection Hyaluronic Acid Therapies For Knee Osteoarthritis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Knee Hyaluronic Acid Injections Market?
The knee hyaluronic acid injections are medical treatments used to relieve joint pain and improve mobility by supplementing the natural hyaluronic acid in the knee. They work by enhancing lubrication and cushioning within the joint, thereby reducing friction and discomfort during movement. These injections are commonly administered as a minimally invasive therapy to support joint function and delay the need for more invasive procedures. The main product types of knee hyaluronic acid injections include single injection, three injection, and five injection. Single injection refers to a viscosupplementation approach where a single dose of hyaluronic acid is administered into the knee joint to improve lubrication and reduce pain in degenerative joint conditions. These treatments are used across indications such as knee osteoarthritis, ligament injury, post arthroscopy, and other indications and they are distributed through hospital pharmacies, retail pharmacies, and online pharmacies. The various applications involved are osteoarthritis, rheumatoid arthritis, and other applications, and they are used by several end users such as hospitals, clinics, ambulatory surgical centers, and other end users.
What Is The Knee Hyaluronic Acid Injections Market Size and Share 2026?
The knee hyaluronic acid injections market size has grown strongly in recent years.It will grow from $3.17 billion in 2025 to $3.37 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising prevalence of osteoarthritis, increasing geriatric population, growing adoption of viscosupplementation therapies, expansion of hospital-based orthopedic treatments, limited historical surgical alternatives.What Is The Knee Hyaluronic Acid Injections Market Growth Forecast?
The knee hyaluronic acid injections market size is expected to see strong growth in the next few years.It will grow to $4.35 billion by 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to advancements in hyaluronic acid formulation technologies, increasing demand for minimally invasive joint treatments, rising healthcare expenditure on orthopedic care, expansion of outpatient and ambulatory surgical infrastructure, growing focus on regenerative and biological therapies.Major trends in the forecast period include rising adoption of single-injection viscosupplementation for osteoarthritis, increasing preference for minimally invasive orthopedic therapies, growing geriatric population driving osteoarthritis treatment demand, expansion of outpatient orthopedic and ambulatory care settings, increasing clinical research on hyaluronic acid molecular weight efficacy.Global Knee Hyaluronic Acid Injections Market Segmentation
1) By Product Type: Single Injection, Three Injection, Five Injection 2) By Indication: Knee Osteoarthritis, Ligament Injury, Post Arthroscopy, Other Indications 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 4) By Application: Osteoarthritis, Rheumatoid Arthritis, Other Applications 5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Single Injection: Cross-Linked Hyaluronic Acid Injections, Non-Cross-Linked Hyaluronic Acid Injections, High Molecular Weight Hyaluronic Acid Injections, Low Molecular Weight Hyaluronic Acid Injections, Visco supplementation Hyaluronic Acid Injections 2) By Three Injection: Cross-Linked Hyaluronic Acid Injections, Non-Cross-Linked Hyaluronic Acid Injections, High Molecular Weight Hyaluronic Acid Injections, Low Molecular Weight Hyaluronic Acid Injections, Visco supplementation Hyaluronic Acid Injections 3) By Five Injection: Cross-Linked Hyaluronic Acid Injections, Non-Cross-Linked Hyaluronic Acid Injections, High Molecular Weight Hyaluronic Acid Injections, Low Molecular Weight Hyaluronic Acid Injections, Visco supplementation Hyaluronic Acid InjectionsWhat Are The Drivers Of The Knee Hyaluronic Acid Injections Market?
The rising incidence of obesity is expected to propel the growth of the knee hyaluronic acid injections industry going forward.Obesity refers to a medical condition characterized by excessive body fat accumulation that presents a risk to health, commonly measured using body mass index (BMI).The incidence of obesity is increasing due to sedentary lifestyles and reduced physical activity levels, which contribute to excessive weight gain and associated health complications.Knee hyaluronic acid injections help manage osteoarthritis symptoms in obese patients by restoring joint lubrication, reducing inflammation, and improving mobility.For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, between 2023 and 2024, an estimated 64.5% of adults aged 18 years and above in England were classified as overweight or obese, representing a slight increase from 64.0% recorded in 2022–2023.Therefore, the rising incidence of obesity is driving growth in the knee hyaluronic acid injections industry. The rising prevalence of knee osteoarthritis (OA) is expected to propel the growth of the knee hyaluronic acid injections industry going forward.Knee osteoarthritis (OA) refers to a degenerative joint disease characterized by the gradual breakdown of cartilage in the knee joint, leading to pain, stiffness, and reduced mobility.The prevalence of knee osteoarthritis is increasing due to aging populations, rising obesity rates, sedentary lifestyles, and growing incidence of joint injuries.Knee hyaluronic acid injections help manage knee osteoarthritis symptoms by improving joint lubrication, reducing pain and inflammation, and enhancing mobility and overall joint function.For instance, in August 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 365 million people globally were living with knee osteoarthritis in 2023, with prevalence continuing to rise due to population aging and increasing obesity levels.Therefore, the rising prevalence of knee osteoarthritis (OA) is driving growth in the knee hyaluronic acid injections industry.Key Players In The Global Knee Hyaluronic Acid Injections Market
Major companies operating in the knee hyaluronic acid injections market are Johnson & Johnson, Sanofi S. A., Teva Pharmaceutical Industries Ltd., Smith & Nephew plc, Chugai Pharmaceutical Co. Ltd., Zimmer Biomet Holdings Inc., Bioventus Inc., Fidia Farmaceutici S. p. A., Ferring Pharmaceuticals A/S, IBSA Institut Biochimique SA, Anika Therapeutics Inc., Lifecore Biomedical LLC, TRB Chemedica International S. A., Seikagaku Corporation, Hangzhou Singclean Medical Products Co. Ltd., Virchow Biotech Private Limited, OrthogenRx Inc., Shanghai Haohai Biological Technology Co. Ltd., Allergan plc, Shandong Freda Biochem Co. Ltd.Global Knee Hyaluronic Acid Injections Market Trends and Insights
Major companies operating in the knee hyaluronic acid injections market are focusing on developing advanced therapies, such as single‑injection HA knee treatments, to restore synovial fluid viscosity, reduce pain, and improve joint function with one intra‑articular administration instead of multiple injections. Single-injection HA knee treatment refers to a medical procedure in which a single dose of hyaluronic acid (HA) is injected into the knee joint to relieve pain and improve mobility, typically in patients with osteoarthritis. For instance, in July 2024, LG Chem, a South Korea‑based life sciences and pharmaceutical company, introduced Synovian (branded in China as Hyruan ONE), a cross‑linked hyaluronic acid injection for knee osteoarthritis in the Chinese market that delivers therapeutic benefits comparable to multi‑injection regimens, simplifies treatment to a single visit, and demonstrated safety and efficacy in Phase‑3 clinical trials among Chinese patients. Synovian’s single‑dose convenience, cross‑linked HA formulation for longer intra‑articular residence, and inclusion on China’s National Reimbursement Drug List support broader adoption and improved patient compliance, though physician training and insurance uptake vary across regions.Regional Insights
North America was the largest region in the knee hyaluronic acid injections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Knee Hyaluronic Acid Injections Market?
The knee hyaluronic acid injections market consists of sales of viscosupplementation injections, single and multi-injection formulations, prefilled syringes, and combination therapeutic products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.What is the Market Assessment and Strategic Outlook for the Knee Hyaluronic Acid Injections Industry?
The knee hyaluronic acid injections market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the knee hyaluronic acid injections industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.What is the Market Assessment and Strategic Outlook for the Knee Hyaluronic Acid Injections Market Report 2026?
The knee hyaluronic acid injections market research report is one of a series of new reports from The Business Research Company that provides knee hyaluronic acid injections market statistics, including knee hyaluronic acid injections industry global market size, regional shares, competitors with a knee hyaluronic acid injections market share, detailed knee hyaluronic acid injections market segments, market trends and opportunities, and any further data you may need to thrive in the knee hyaluronic acid injections industry. This knee hyaluronic acid injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.Knee Hyaluronic Acid Injections Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.37 billion |
| Revenue Forecast In 2035 | $4.35 billion |
| Growth Rate | CAGR of 6.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Indication, Distribution Channel, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Johnson & Johnson, Sanofi S. A., Teva Pharmaceutical Industries Ltd., Smith & Nephew plc, Chugai Pharmaceutical Co. Ltd., Zimmer Biomet Holdings Inc., Bioventus Inc., Fidia Farmaceutici S. p. A., Ferring Pharmaceuticals A/S, IBSA Institut Biochimique SA, Anika Therapeutics Inc., Lifecore Biomedical LLC, TRB Chemedica International S. A., Seikagaku Corporation, Hangzhou Singclean Medical Products Co. Ltd., Virchow Biotech Private Limited, OrthogenRx Inc., Shanghai Haohai Biological Technology Co. Ltd., Allergan plc, Shandong Freda Biochem Co. Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
